Detailed Narrative
Strategic Plan Outperformance
The company is outperforming key objectives of its strategic plan laid out a year ago, including average same-store NOI growth of 5.7%, same-store occupancy near 93%, retention near 90%, and cash leasing spreads of 4.1%. This outperformance has led to raised guidance every quarter, including a $0.02 increase this quarter, driven by strong operations, leasing, a successful convertible bond offering, and accretive capital allocation.
Leasing Success & ROI
Year-to-date, the company executed 3.5 million square feet of leases, representing over 10% of its total portfolio, and increased its weighted average remaining lease term to 65 months, an improvement of 15 months. A new leasing model has improved lease IRRs by nearly 3,000 basis points and reduced payback periods by nearly 25%, aiming to meaningfully rerate core earnings growth.
Health System Partnerships
Dialogue and collaboration with health systems have increased, leading to significant transactions. This includes 160,000 sq ft of renewals with CommonSpirit at a 7% cash spread, coupled with a $16 million land sale and retained MOB development rights. With Wellstar, 215,000 sq ft of renewals at a 4% cash spread and a $36 million MOB sale at a mid-5% cap rate were executed. An LOI with Ascension St. Thomas for 203,000 sq ft of leases at an 11% cash spread and a $35 million redevelopment investment is also underway.
Capital Allocation Strategy
The company's capital allocation prioritizes redevelopments, joint venture acquisitions, balance sheet management, and shareholder returns, funded by free cash flow and disposition proceeds. They invested $25 million in redevelopments in Q2, targeting 10% cash-on-cash yields. Year-to-date, they disposed of 6 buildings and 3 land parcels for $75 million at a blended 5% cap rate, with an additional $200 million disposition pipeline.
Balance Sheet & Liquidity
Healthcare Realty addressed near-term debt maturities by raising $1.1 billion through a $700 million exchangeable senior unsecured note issuance (3% coupon, due 2032) and a $400 million unsecured delayed draw term loan. This capital, blended at approximately 4% interest, saved 100 basis points versus original guidance and extended maturities through 2027, providing $1.2 billion in line of credit liquidity through 2029.
JV Acquisitions with KKR
The partnership with KKR has resulted in approximately $200 million in acquisitions (or $40 million at HR's share) closed, under contract, or LOI since the last call. These transactions offer an approximate 7.5% cash yield to Healthcare Realty, highly accretive relative to the company's implied cap rate of 6%, and are efficiently match-funded by dispositions.
Market Fundamentals
Medical outpatient completions are near all-time lows, while sector occupancy reaches record highs, creating a favorable supply-demand backdrop. Increased health system M&A activity is also observed, which can lead to stronger tenant credit and additional capital sources, driving demand for outpatient medical space.
Future Outlook
The company aims to scale its 'new superior medical office model' over the next several years, focusing on organic growth pillars (occupancy, retention, cash leasing spreads, consistent escalators) and disciplined, accretive capital allocation. They see meaningful upside as the only public REIT actively growing its medical office platform, intending to lead the sector.